Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 2/20 | 0.52 |
| ▸ | CDK2 | P24941 | 5/20 | 0.49 |
| ▸ | ITGB1 | P05556 | 3/20 | 0.47 |
| ▸ | ITGA4 | P13612 | 3/20 | 0.47 |
| ▸ | ITGB7 | P26010 | 3/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.46 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.46 |
| ▸ | TACR3 | P29371 | 1/20 | 0.46 |
| ▸ | ELANE | P08246 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6497424 | 1.00 | ECE1 (0.52) | ECE1CDK2ITGB1ITGA4ITGB7 | |
| SCHEMBL4827805 | 0.97 | CDK2 (0.51) | ECE1CDK2HDAC1HDAC6TACR3 | |
| SCHEMBL4833482 | 0.97 | CDK2 (0.51) | ECE1CDK2HDAC1HDAC6TACR3 | |
| SCHEMBL4833581 | 0.94 | CDK2 (0.51) | ECE1CDK2HDAC1HDAC6TACR3 | |
| SCHEMBL4833586 | 0.94 | CDK2 (0.51) | ECE1CDK2HDAC1HDAC6TACR3 | |
| SCHEMBL4827782 | 0.93 | ECE1 (0.53) | ECE1ITGB1ITGA4ITGB7ERAP1 | |
| SCHEMBL4827784 | 0.93 | ECE1 (0.53) | ECE1ITGB1ITGA4ITGB7ERAP1 | |
| SCHEMBL3991898 | 0.91 | CDK2 (0.49) | ECE1CDK2HDAC1HDAC6TACR3 | |
| SCHEMBL13792618 | 0.91 | CDK2 (0.49) | ECE1CDK2HDAC1HDAC6TACR3 | |
| SCHEMBL5927133 | 0.90 | CDK2 (0.49) | ECE1CDK2ITGB1ITGA4HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005014534-A1 | ARYL AND HETEROARYL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | TRANSTECH PHARMA, INC. (US) | 2005-02-17 | — | — | WO | disclosed |